Cardiovascular effects of orciprenaline (Alupent) inhalation and prednisolone.
D000281:Administration, Intranasal; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D004285:Dogs; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D009921:Metaproterenol / Q000494:pharmacology*; D009200:Myocardial Contraction / Q000187:drug effects; D011239:Prednisolone / Q000494:pharmacology*; D013997:Time Factors; D014655:Vascular Resistance / Q000187:drug effects
D009921:Metaproterenol; D011239:Prednisolone